Analystreport

Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) had its "overweight" rating re-affirmed by analysts at RBC Capital Markets.

Alexion Pharmaceuticals, Inc  (ALXN) 
Last alexion pharmaceuticals, inc earnings: 1/30 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.alexion.com/investor-relations